Fig. 2.
Characterization and mRNA delivery efficiency of F-PEI. (a) Agarose gel electrophoresis of F-PEI/mRNA at different w/w ratios. (b) Dynamic light scattering analysis of F-PEI/mRNA. (c) Transmission electron microscopy imaging shown F13-PEI1.8k-1/mRNA and F13-PEI1.8k-2/mRNA. Scale bar = 200 nm. (d) Zeta potentials of the F13-PEI1.8k-1, F13-PEI1.8k-2, mRNA, F13-PEI1.8k-1/mRNA and F13-PEI1.8k-2/mRNA. (e&f) Representative flow cytometry plots (e) and the mean fluorescence intensity (MFI) of Cy5 (f) in BMDCs incubated with F-PEI/Cy5-mRNALuc for 6 h. (g&h) F-PEI/mRNALuc (10 μg mRNALuc per mouse) was intradermally injected at the tail base of mice to evaluate the in vivo mRNA delivery efficiency, and the bioluminescence images (g) and statistical data (h) were recorded at 6 h and 24 h post injection. d,f, The data show mean ± standard deviation (n = 3). h, The data show mean ± standard error of mean (n = 3 mice per group). f,h, Statistical significance between the indicated groups was determined using two-sided unpaired t-tests. **P < 0.01, ***P < 0.001.